NADclinic Has Appointed Dr Tony Banerjee as Global Chief Medical Officer
In a powerful move set to redefine the future of longevity, performance and preventative medicine, NADclinic has appointed Dr Tony Banerjee, Founder and CEO of HarleyDoc, as its Global Chief Medical Officer, following a strategic partnership between the two visionary healthcare platforms.
The appointment builds on the successful collaboration behind Superhumxn+, a medically-governed peak performance and longevity initiative that brought together NADclinic’s advanced optimisation protocols with HarleyDoc’s global clinical governance and concierge healthcare infrastructure. What began as a shared belief in restoring rigour, accountability and evidence to the longevity space has now evolved into a longterm partnership designed to reshape an increasingly crowded and commercially driven market.
At a time when longevity has become saturated with trends, promises and influencer-led narratives, HarleyDoc and NADclinic are uniting to bring longevity back to medicine, grounded in diagnostics, governance, and data-backed science.
Under the partnership, NADclinic, a leading UK and international longevity, diagnostics and performance optimisation brand which offers IV DRIPS, supplements and their new SQx Smart Pen, integrates HarleyDoc’s clinical leadership, governance frameworks and global medical escalation pathways across its UK and international operations.
Dr Tony Banerjee’s appointment as Global Chief Medical Officer strengthens clinical oversight, regulatory readiness and medical accountability across NADclinic’s expanding footprint, which spans clinics, wellness destinations, private members’ environments, hospitality and corporate settings.
Together, the two organisations are building a globally scalable, medically governed ecosystem designed to support well individuals seeking optimisation, while ensuring robust clinical safeguards and rapid escalation when required.
Iain De Havilland, Founder & CEO of NADclinic, commented: “Our ambition has always been to scale longevity and performance globally without compromising on safety, integrity or science. Partnering with HarleyDoc and appointing Dr Tony Banerjee as our Global Chief Medical Officer brings an unparalleled level of clinical governance, international assurance and leadership. This marks a defining moment in NADclinic’s evolution.”
Dr Tony Banerjee, Founder & CEO of HarleyDoc and Global Chief Medical Officer of NADclinic, added: “Longevity is at a crossroads. This partnership represents a return to medicine - to structure, accountability and data-led care. Through Superhuman+, we saw what was possible when governance and optimisation work together. Now, we are building something far bigger: a future-ready, globally scalable model for longevity that is safe, intelligent and medically led.”
This partnership establishes a model where optimisation, preventative medicine and performance enhancement are delivered within a clear medical framework, supported by 24/7/365 global clinical access, structured pathways and physician-led governance.
HarleyDoc will act as NADclinic’s global clinical infrastructure and escalation partner, while NADclinic continues to lead on longevity protocols, diagnostics, IV therapies and performance programmes within its established operational frameworks. Two entrepreneurs. One shared mission.
Both founded by entrepreneurs with a deep respect for medicine, data and patient safety, HarleyDoc and NADclinic share a clear ambition: to future-proof longevity by anchoring it in evidence, ethics and elite clinical leadership.
The partnership reflects a growing shift away from trend-led wellness towards mediabacked science, physician authority and measurable outcomes, a direction increasingly demanded by high-performing individuals and global clients alike.
